Literature DB >> 14501919

A modeling capacity of vertebral fractures exists during growth: an up-to-47-year follow-up.

Magnus K Karlsson1, Karlsson K Magnus, Anders Moller, Moller Anders, Ralph Hasserius, Hasserius Ralph, Jack Besjakov, Besjakov Jack, Caroline Karlsson, Karlsson Caroline, Acke Ohlin, Ohlin Acke.   

Abstract

STUDY
DESIGN: The study is an observational cohort study.
OBJECTIVES: To determine the incidence and the long-term outcome of thoracic or lumbar vertebral fractures in children. SUMMARY OF BACKGROUND DATA: The incidence of vertebral fractures in children is described as rare and the outcome as favorable. However, no studies evaluate the clinical and radiographic long-term outcome and if a fractured vertebra could be rebuilt during growth.
METHOD: The incidence of vertebral fractures in children was evaluated through the radiographic archives. Twelve boys and 12 girls, aged 7-16 when sustaining the fracture, 21 one-column compression fractures and 3 burst fractures Denis type B, all without neurologic deficits, attended the follow-up. Primary treatment consisted of immediate mobilization without brace. Clinical and radiographic examinations were performed 27-47 years after the injury.
RESULTS: The annual incidence of thoracic and lumbar vertebral body fractures in individuals below age 16 was 0.07%. Twenty-one individuals had, at follow-up, no subjective complaints, 3 had occasional back pain (Oswestry Scores 8, 22, and 26), 23 were classified as Frankel E, and 1 as Frankel D. The radiographic ratio anterior height/posterior height of the fractured vertebral body increased from 0.75 after injury to 0.87 at follow-up (P < 0.001). The posttraumatic kyphosis in the fractured region decreased in 8 individuals (33%), all aged 13 or less at fracture. No increased disc degeneration was observed.
CONCLUSION: Thoracolumbar vertebral fractures without neurologic deficits, sustained during growth, have a favorable long-term outcome. A modeling capacity, reducing the fracture deformity, exists at least in the youngest patients.

Entities:  

Mesh:

Year:  2003        PMID: 14501919     DOI: 10.1097/01.BRS.0000084680.76654.B1

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Vertebral fractures in late adolescence: a 27 to 47-year follow-up.

Authors:  Anders Moller; Ralph Hasserius; Jack Besjakov; Acke Ohlin; Magnus Karlsson
Journal:  Eur Spine J       Date:  2006-01-05       Impact factor: 3.134

Review 2.  Growth, children, and fractures.

Authors:  Graeme Jones
Journal:  Curr Osteoporos Rep       Date:  2004-09       Impact factor: 5.096

3.  Post-trauma scoliosis after conservative treatment of thoracolumbar spinal fracture in children and adolescents: results in 48 patients.

Authors:  Audrey Angelliaume; Aurore Bouty; Jérôme Sales De Gauzy; Jean-Marc Vital; Olivier Gille; Louis Boissière; Clément Tournier; Stéphane Aunoble; Jean-Roger Pontailler; Yan Lefèvre
Journal:  Eur Spine J       Date:  2015-01-09       Impact factor: 3.134

4.  The influence of brace immobilization on the remodeling potential of thoracolumbar impaction fractures in children and adolescents.

Authors:  Georg Singer; Stephan Parzer; Christoph Castellani; Helmut Wegmann; Franz Lindbichler; Holger Till; Robert Eberl
Journal:  Eur Spine J       Date:  2015-09-28       Impact factor: 3.134

5.  Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.

Authors:  Jinhui Ma; Kerry Siminoski; Nathalie Alos; Jacqueline Halton; Josephine Ho; Elizabeth A Cummings; Nazih Shenouda; Mary Ann Matzinger; Brian Lentle; Jacob L Jaremko; Beverly Wilson; David Stephure; Robert Stein; Anne Marie Sbrocchi; Celia Rodd; Victor A Lewis; Caroline Laverdière; Sara Israels; Ronald M Grant; Conrad V Fernandez; David B Dix; Robert Couch; Elizabeth Cairney; Ronald Barr; Stephanie Atkinson; Sharon Abish; David Moher; Frank Rauch; Leanne M Ward
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.